Title:
HETEROCYCLIC COMPOUND
Document Type and Number:
WIPO Patent Application WO/2018/052058
Kind Code:
A1
Abstract:
The present invention provides: a heterocyclic compound which has an IRAK-4-inhibiting activity and is expected to be useful for the prevention/treatment of inflammatory diseases, autoimmune diseases, osteoarticular degenerative diseases, neoplastic diseases and the like; and a medicine containing the heterocyclic compound.
The present invention relates to a compound represented by formula (I) [wherein each symbol is as defined in the description] or a salt thereof.
Inventors:
YOSHIDA MASATO (JP)
TOMINARI YUSUKE (JP)
SHIOKAWA ZENYU (JP)
SHIBUYA AKITO (JP)
TAKAMI KAZUAKI (JP)
GIBSON TONY (US)
SUZUKI SHINKICHI (JP)
TOMINARI YUSUKE (JP)
SHIOKAWA ZENYU (JP)
SHIBUYA AKITO (JP)
TAKAMI KAZUAKI (JP)
GIBSON TONY (US)
SUZUKI SHINKICHI (JP)
Application Number:
PCT/JP2017/033199
Publication Date:
March 22, 2018
Filing Date:
September 14, 2017
Export Citation:
Assignee:
TAKEDA PHARMACEUTICALS CO (JP)
International Classes:
C07D401/14; A61K31/4439; A61P29/00; A61P37/06; A61P43/00; C07D413/14; C07D487/10
Domestic Patent References:
| WO2015068856A1 | 2015-05-14 | |||
| WO2011043371A1 | 2011-04-14 | |||
| WO2006070198A1 | 2006-07-06 | |||
| WO2012108511A1 | 2012-08-16 |
Foreign References:
| JP2011506361A | 2011-03-03 | |||
| JP2014001205A | 2014-01-09 | |||
| JPS63250376A | 1988-10-18 | |||
| JPS5931763A | 1984-02-20 |
Attorney, Agent or Firm:
TAKASHIMA, Hajime et al. (JP)
Download PDF: